My husband is participating in a clinical trial at NIH.  It’s a Phase 1, First in Human trial for kidney cancer.

Just prior to and after enrollment I think Ralph had every diagnostic test known to man.  Chest abdomen CT scan, CT/PET, EKG, chest x-ray, bone scan, Brain MRI, pulmonary function test, venous access assessment, echo-cardiogram, (2) cardiac MRI’s and a VQ.  I’ve lost count of the tubes of blood drawn. He was poked, prodded, examined and scanned. Through it all though, he was a pretty good sport.

This particular clinical trial is a gene transfer trial.  After all the diagnostic tests, the first step in the protocol was a collection of Ralph’s white blood cells.   This is a blood collection process called leukapheresis.  It’s all done thru a fancy machine, where the blood is cycled through the machine, the cells are separated, the white blood cells are collected and the rest is returned.

As you can see from the picture, it’s not a painful process – just a long 5 hour process.  We then had to wait about 4 weeks for the white blood cells to go to Loyola in Chicago and be genetically modified into super fighter T-cells.

Several days before the new modified T-cells are infused, they must make room by killing off existing T-cells through chemotherapy.  This was done over the past 3 days.  The only complication is fluid retention and oxygen issues related to chemotherapy & disease.  All of Ralph’s disease is in the chest, lungs & pericardium area.  The heart is impaired due to a tumor and prior radiation.  He is a complicated patient and its always a very delicate balance.  God bless Oncologists!

We have lived through the disappointment of numerous failed treatments.  However, we’re really excited about this opportunity and cutting-edge treatment for kidney cancer.

Good news!  The super T-cells are back and the next part begins!

 

WHO WE ARE →

WHAT WE DO →

OUR STORIES →

THE KIDNEY CANCER COMMUNITY →

SCIENTIFIC ADVISORS →

DONATE →

CONTACT →

Latest News

Empowering Young Voices: The Role of Youth in Kidney Cancer Advocacy

Empowering Young Voices: The Role of Youth in Kidney Cancer Advocacy

Scarlett Talcott, a vibrant 11-year-old from southern Montana, stands confidently in front of the Capitol Building during KidneyCAN's Advocacy Day. Living on a ranch with her parents, sister, and two brothers, Scarlett balances her love for the arts, crafting, and 4-H activities with a strong...

SPRING ADVOCACY DAYS 2024 →

JOIN OUR COMMUNITY →

RAISING AWARENESS →

BE AN ADVOCATE →

DONATE NOW →

CONTACT →

Latest News

Empowering Young Voices: The Role of Youth in Kidney Cancer Advocacy

Empowering Young Voices: The Role of Youth in Kidney Cancer Advocacy

Scarlett Talcott, a vibrant 11-year-old from southern Montana, stands confidently in front of the Capitol Building during KidneyCAN's Advocacy Day. Living on a ranch with her parents, sister, and two brothers, Scarlett balances her love for the arts, crafting, and 4-H activities with a strong...

Patient Resource Center

UNDERSTANDING YOUR KIDNEY CANCER DIAGNOSIS

BUILDING YOUR CARE TEAM

TREATMENT & TRIAL OPTIONS

LIVING WELL WITH KIDNEY CANCER
kidney cancer and the military

KIDNEY CANCER & THE MILITARY

CLINICAL TRIALS →

IMMUNOTHERAPY →

RESEARCH UPDATES →

SURVIVORSHIP →

OPTIMIZING YOUR KIDNEY HEALTH →

HANDLING HOLIDAYS WITH CANCER →

KCRS: KIDNEY CANCER RESEARCH SUMMIT →

RESEARCH OPPORTUNITIES →

NEWS →

Latest News

Dr. Yousef Zakharia: “I Believe in Teamwork”

Dr. Yousef Zakharia: “I Believe in Teamwork”

For this Community Spotlight feature, we spoke to Dr. Yousef Zakharia, a medical oncologist at the Holden Comprehensive Cancer Center and associate professor at the University of Iowa. Dr. Zakharia shares important information about finding the best care at NCI-designated centers, as well as his...

SUPPORT OUR WORK →

ROCK THE RUN 2023 →

FUNDRAISE FOR KIDNEYCAN →

DONATE →

CONTACT →

Latest News